Zhang Kailiang, Zhang Yinglong, Ren Kun, Zhao Guangyi, Yan Kang, Ma Baoan
Department of Orthopedic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China.
Oncol Rep. 2014 Nov;32(5):2143-9. doi: 10.3892/or.2014.3459. Epub 2014 Sep 2.
MicroRNAs (miRNAs) are a class of small non‑coding RNA molecules, which play regulatory roles at the post-transcriptional level by suppressing the translation of protein‑coding genes or inducing mRNA cleavage. Dysregulated expression of miRNAs is involved in multiple types of cancers and plays important roles in regulating various biological processes including metastasis. miR-101 is downregulated in various types of cancer and functions as a suppressor of cell migration and invasion. Meanwhile, enhancer of zeste homolog 2 (EZH2) is associated with the metastatic potential of several aggressive tumors. In the present study, we reported that ectopic overexpression of miR-101 downregulated the expression level of EZH2 and significantly inhibited migration and invasion of osteosarcoma cells. In addition, knockdown of EZH2 by siRNA showed the same effect of miR-101 on migration and invasion. To conclude, these results indicate that miR-101 may act as a tumor suppressor in osteosarcoma, as it has a suppressive role in cell migration and invasion by targeting EZH2.
微小RNA(miRNA)是一类小的非编码RNA分子,其通过抑制蛋白质编码基因的翻译或诱导mRNA切割在转录后水平发挥调节作用。miRNA表达失调与多种癌症相关,并在调节包括转移在内的各种生物学过程中发挥重要作用。miR-101在多种类型的癌症中表达下调,并作为细胞迁移和侵袭的抑制因子发挥作用。同时,zeste同源物2增强子(EZH2)与几种侵袭性肿瘤的转移潜能相关。在本研究中,我们报道miR-101的异位过表达下调了EZH2的表达水平,并显著抑制了骨肉瘤细胞的迁移和侵袭。此外,通过小干扰RNA(siRNA)敲低EZH2显示出与miR-101对迁移和侵袭相同的作用。总之,这些结果表明miR-101可能作为骨肉瘤中的肿瘤抑制因子,因为它通过靶向EZH2对细胞迁移和侵袭具有抑制作用。